Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-16

FDA Approved: RUFINAMIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's original application for Rufinamide, providing a generic version of the anticonvulsant. Rufinamide is indicated as adjunctive therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)